Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Zyrexindo Mandiri Buana Tbk. (ZYRX)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan UBC Medical Indonesia Tbk. dan Zyrexindo Mandiri Buana Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Zyrexindo Mandiri Buana Tbk. diperdagangkan di Rp129 (kapitalisasi pasar 170,67 M, volume 24 jam 1,26 jt). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 3,4× kapitalisasi pasar Zyrexindo Mandiri Buana Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (3,48 jt vs 1,26 jt). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | ZYRX | |
|---|---|---|
Kapitalisasi Pasar | 576,7 M | 170,67 M |
Volume | 3,48 jt | 1,26 jt |
Lot | 34,82 rb | 12,6 rb |
Perputaran | 522,79 jt | 162,38 jt |
Harga Rata-rata | 150,13 | 128,9 |
Nilai Transaksi | 522,79 jt | 162,38 jt |
Harga Ekuilibrium Indikatif | 148 | 129 |
Volume Ekuilibrium Indikatif | 350 | 233 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →Tentang Zyrexindo Mandiri Buana Tbk.
PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Selengkapnya di halaman ZYRX →
